These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 21743990)

  • 1. Higher tacrolimus blood concentration is related to hyperlipidemia in living donor liver transplantation recipients.
    Li HY; Li B; Wei YG; Yan LN; Wen TF; Zhao JC; Xu MQ; Wang WT; Ma YK; Yang JY
    Dig Dis Sci; 2012 Jan; 57(1):204-9. PubMed ID: 21743990
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Higher tacrolimus blood concentration is related to increased risk of post-transplantation diabetes mellitus after living donor liver transplantation.
    Song JL; Li M; Yan LN; Yang JY; Yang J; Jiang L
    Int J Surg; 2018 Mar; 51():17-23. PubMed ID: 29360611
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tacrolimus dosage requirements in living donor liver transplant recipients with small-for-size grafts.
    Liu F; Li Y; Lan X; Wei YG; Li B; Yan LN; Wen TF; Zhao JC; Xu MQ; Wang WT; Yang JY
    World J Gastroenterol; 2009 Aug; 15(31):3931-6. PubMed ID: 19701975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal blood levels of (extended-release) tacrolimus in living donor kidney transplantation to prevent de novo donor-specific antibody production: A retrospective cohort study.
    Hiramitsu T; Tomosugi T; Futamura K; Okada M; Nishihira M; Goto N; Ichimori T; Narumi S; Kobayashi T; Uchida K; Watarai Y
    Int Immunopharmacol; 2021 Feb; 91():107038. PubMed ID: 33388731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lower tacrolimus trough levels in the late period after living donor liver transplantation contribute to improvements in long-term clinical outcomes.
    Geng L; Wang LD; Huang JJ; Shen T; Wang ZY; Lin BY; Ye YF; Zheng SS
    Hepatobiliary Pancreat Dis Int; 2018 Jun; 17(3):204-209. PubMed ID: 29807766
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 12-month follow-up analysis of a multicenter, randomized, prospective trial in de novo liver transplant recipients (LIS2T) comparing cyclosporine microemulsion (C2 monitoring) and tacrolimus.
    Levy G; Grazi GL; Sanjuan F; Wu Y; Mühlbacher F; Samuel D; Friman S; Jones R; Cantisani G; Villamil F; Cillo U; Clavien PA; Klintmalm G; Otto G; Pollard S; McCormick PA
    Liver Transpl; 2006 Oct; 12(10):1464-72. PubMed ID: 17004259
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The renal-sparing efficacy of basiliximab in adult living donor liver transplantation.
    Lin CC; Chuang FR; Lee CH; Wang CC; Chen YS; Liu YW; Jawan B; Chen CL
    Liver Transpl; 2005 Oct; 11(10):1258-64. PubMed ID: 16184544
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hyperlipidemia in Iranian liver transplant recipients: prevalence and risk factors.
    Dehghani SM; Taghavi SA; Eshraghian A; Gholami S; Imanieh MH; Bordbar MR; Malek-Hosseini SA
    J Gastroenterol; 2007 Sep; 42(9):769-74. PubMed ID: 17876547
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus.
    Taylor DO; Barr ML; Radovancevic B; Renlund DG; Mentzer RM; Smart FW; Tolman DE; Frazier OH; Young JB; VanVeldhuisen P
    J Heart Lung Transplant; 1999 Apr; 18(4):336-45. PubMed ID: 10226898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of tacrolimus and mycophenolate mofetil regimen vs. a conventional therapy with steroids on cardiovascular risk in liver transplant patients.
    Cuervas-Mons V; Herrero JI; Gomez MA; González-Pinto I; Serrano T; de la Mata M; Fabregat J; Gastaca M; Bilbao I; Varo E; Sánchez-Antolín G; Rodrigo J; Espinosa MD
    Clin Transplant; 2015 Aug; 29(8):667-77. PubMed ID: 25924549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors predicting long-term graft survival after kidney transplantation: multicenter study in Japan.
    Akioka K; Takahara S; Ichikawa S; Yoshimura N; Akiyama T; Ohshima S
    World J Surg; 2005 Feb; 29(2):249-56. PubMed ID: 15654657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months.
    Gonwa T; Mendez R; Yang HC; Weinstein S; Jensik S; Steinberg S;
    Transplantation; 2003 Apr; 75(8):1213-20. PubMed ID: 12717205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between lipid abnormalities and immunosuppressive therapy in renal transplant recipients with stable renal function.
    Perrea DN; Moulakakis KG; Poulakou MV; Vlachos IS; Nikiteas N; Kostakis A
    Int Urol Nephrol; 2008; 40(2):521-7. PubMed ID: 17978855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of the post-operative pulmonary infection in adult-to-adult living donor liver transplant recipients].
    Liu F; Li B; Feng X; Wei YG; Li Y
    Zhonghua Gan Zang Bing Za Zhi; 2009 Aug; 17(8):611-4. PubMed ID: 19719921
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Late-onset acute rejection after living donor liver transplantation.
    Akamatsu N; Sugawara Y; Tamura S; Keneko J; Matsui Y; Hasegawa K; Makuuchi M
    World J Gastroenterol; 2006 Nov; 12(41):6674-7. PubMed ID: 17075982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequency and severity of acute rejection in live- versus cadaveric-donor renal transplants.
    Campbell SB; Hothersall E; Preston J; Brown AM; Hawley CM; Wall D; Griffin AD; Isbel NM; Nicol DL; Johnson DW
    Transplantation; 2003 Nov; 76(10):1452-7. PubMed ID: 14657685
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tacrolimus dosing requirements and concentrations in adult living donor liver transplant recipients.
    Taber DJ; Dupuis RE; Fann AL; Andreoni KA; Gerber DA; Fair JH; Johnson MW; Shrestha R
    Liver Transpl; 2002 Mar; 8(3):219-23. PubMed ID: 11910566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous Administration of Tacrolimus Stabilizes Control of Blood Concentration Regardless of CYP3A5 Polymorphism in Living Donor Liver Transplantation: Comparison of Intravenous Infusion and Oral Administration in Early Postoperative Period.
    Kato H; Usui M; Muraki Y; Okuda M; Nakatani K; Hayasaki A; Ito T; Iizawa Y; Murata Y; Tanemura A; Kuriyama N; Azumi Y; Kishiwada M; Mizuno S; Sakurai H; Isaji S
    Transplant Proc; 2018 Nov; 50(9):2684-2689. PubMed ID: 30401377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tacrolimus in pancreas transplantation: a multicenter analysis. Tacrolimus Pancreas Transplant Study Group.
    Gruessner RW
    Clin Transplant; 1997 Aug; 11(4):299-312. PubMed ID: 9267719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prednisone withdrawal 14 days after liver transplantation with mycophenolate: a prospective trial of cyclosporine and tacrolimus.
    Stegall MD; Wachs ME; Everson G; Steinberg T; Bilir B; Shrestha R; Karrer F; Kam I
    Transplantation; 1997 Dec; 64(12):1755-60. PubMed ID: 9422416
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.